Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Epilepsy | Case report

Bergmeister’s papilla in a young patient with type 1 sialidosis: case report

Authors: Settimio Rossi, Carlo Gesualdo, Antonio Tartaglione, Leonilda Bilo, Antonietta Coppola, Francesca Simonelli

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Sialidosis is a rare genetic lysosomal storage disorder caused by a deficit of neuraminidase enzyme activity. Patients with sialidosis present various neurological disorders such as: myoclonic epilepsy and hypotonia, often associated with visual impairment. A typical aspect of sialidosis is the finding of a macular cherry-red spot on ocular fundus examination. In this paper we describe a unilateral case of Bergmeister’s papilla (BP) in a young female patient suffering from type 1 sialidosis.

Case presentation

A 28-year-old young woman suffering from type 1 sialidosis, confirmed by previously described compound heterozigosity Leu91Arg and Gly328Ser on N-acetyl-alpha-neuraminidase − 1 (NEU1) gene, underwent an opthalmological examination at the Eye Clinic of the University of Campania L. Vanvitelli, for bilateral visual deterioration. The patient was suffering from myoclonic epilepsy with hypotonia and severe motor disability. Fundoscopic examination showed a typical macular cherry-red spot with retinal pigment epithelium dystrophy in the middle periphery, in both eyes. Furthermore, in the left eye (OS), a vitreous thickening was observed in the nasal sector of the optic disc, remnant of fetal vasculature on the optic disc (Bergmeister’s papilla). Optical coherence tomography (OCT) showed, in both eyes, a thickening of the ganglion cell layer (GCL) with a hyperreflective opacity as a cap on the left optic disc.

Conclusions

In our paper we have described, for the first time in literature, a case of BP in a patient with type 1 sialidosis. The detection of BP with thickening of the peripapillary vitreous by SD-OCT is useful in monitoring any vitreo-retinal change that could cause future visual deterioration.
Literature
3.
go back to reference Caciotti A, Melani F, Tonin R, Cellai L, Catarzi S, Procopio E, Chilleri C, Mavridou I, Michelakakis H, Fioravanti A, d'Azzo A, Guerrini R, Morrone A. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: an overview. Mol Genet Metab. 2020;129(2):47–58. https://doi.org/10.1016/j.ymgme.2019.09.005 Epub 2019 Oct 31. Review.CrossRefPubMed Caciotti A, Melani F, Tonin R, Cellai L, Catarzi S, Procopio E, Chilleri C, Mavridou I, Michelakakis H, Fioravanti A, d'Azzo A, Guerrini R, Morrone A. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: an overview. Mol Genet Metab. 2020;129(2):47–58. https://​doi.​org/​10.​1016/​j.​ymgme.​2019.​09.​005 Epub 2019 Oct 31. Review.CrossRefPubMed
5.
go back to reference Rosenberg R, Halimi E, Mention-Mulliez K, Cuisset JM, Holder M, Defoort-Dhellemmes S. Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis. J Pediatr Ophthalmol Strabismus. 2013;50 Online:e33–e36. doi:https://doi.org/10.3928/01913913-20130625-02. Rosenberg R, Halimi E, Mention-Mulliez K, Cuisset JM, Holder M, Defoort-Dhellemmes S. Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis. J Pediatr Ophthalmol Strabismus. 2013;50 Online:e33–e36. doi:https://​doi.​org/​10.​3928/​01913913-20130625-02.
7.
go back to reference Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996;10(24):3156–69.CrossRef Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996;10(24):3156–69.CrossRef
8.
go back to reference Lukong KE, Landry K, Elsliger MA, Chang Y, Lefrancois S, Morales CR, Pshezhetsky AV. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex. J Biol Chem. 2001;276:17286–90.CrossRef Lukong KE, Landry K, Elsliger MA, Chang Y, Lefrancois S, Morales CR, Pshezhetsky AV. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex. J Biol Chem. 2001;276:17286–90.CrossRef
10.
go back to reference Michalewska Z, Gajos A, Michalewski J, Nawrocki J, Pshezhetsky AV, Bogucki A. Spectral optical coherence tomography in a patient with type I sialidosis. Med Sci Monit. 2011;17(10):CS129–31.CrossRef Michalewska Z, Gajos A, Michalewski J, Nawrocki J, Pshezhetsky AV, Bogucki A. Spectral optical coherence tomography in a patient with type I sialidosis. Med Sci Monit. 2011;17(10):CS129–31.CrossRef
Metadata
Title
Bergmeister’s papilla in a young patient with type 1 sialidosis: case report
Authors
Settimio Rossi
Carlo Gesualdo
Antonio Tartaglione
Leonilda Bilo
Antonietta Coppola
Francesca Simonelli
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Epilepsy
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01628-1

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue